Company intelligence / Profile preview

QuikCycle

Salt Lake City, Utah, USA

Ownership: Private
Development stage: Other

Overview

QuikCycle is a biotechnology company that developed a proprietary rapid thermal cycling technology for Polymerase Chain Reaction (PCR) testing. The company's innovation enables ultra-fast nucleic acid amplification, reducing the time required for molecular diagnostic results from hours to minutes. QuikCycle was acquired by Co-Diagnostics in December 2021 to serve as a foundational component of the Co-Dx PCR Home platform, a point-of-care diagnostic device. This technology aims to provide laboratory-grade accuracy in decentralized settings for the detection of infectious diseases such as COVID-19 and influenza.

Therapeutic areas: Infectious Diseases
Modalities: Molecular DiagnosticsDevice
Industry: Molecular Diagnostics

Partnerships

Idaho Molecular

Beyond the preview

Go deeper on QuikCycle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QuikCycle.

Explore the full profile